scholarly journals Irritability, Poor Feeding and Respiratory Alkalosis in Newborns: Think about Metabolic Emergencies. A Brief Summary of Hyperammonemia Management

2020 ◽  
Vol 12 (3) ◽  
pp. 77-85
Author(s):  
Stefano Del Re ◽  
Aurélie Empain ◽  
Alfredo Vicinanza ◽  
Ovidiu Balasel ◽  
Anne-Britt Johansson ◽  
...  

The urea cycle is a series of metabolic reactions that convert ammonia into urea in order to eliminate it from the body. Urea cycle disorders are characterized by hyperammonemia, which can cause irreversible damages in central nervous system. We report a series of three newborns presenting irritability, poor feeding and tachypnea. Their first gas analysis revealed respiratory alkalosis. Hyperammonemia was confirmed, and three different enzymatic blocks in the urea cycle were diagnosed. Immediate treatment consisted in the removal of ammonia by reduction of the catabolic state, dietary adjustments, use of nitrogen scavenging agents and ultimately hemodiafiltration. Hyperammonemia is a medical emergency whose treatment should not be delayed. This report aims to highlight the importance of suspecting urea cycle disorders in newborns with aspecific signs of hyperammonemia and respiratory alkalosis, and to sum up the broad lines of hyperammonemia management.

Author(s):  
Stefan Kölker ◽  
Johannes Häberle ◽  
Valerie Walker

The urea cycle is the final pathway for removal of surplus nitrogen from the body, the major route in humans for irreversible detoxification of ammonia and a source of arginine.2,3 Patients with adult-onset urea cycle disorders present with clinical symptoms that have a broad differential diagnosis (e.g., protein aversion, inappetence, cyclic vomiting, epilepsy, psychiatric disease, migraine, liver dysfunction). Unlike infants and children some adult-onset patients may never develop acute hyperammonemic crises. Since symptoms are often fluctuating and the diagnosis can only be made if specific tests are made, the diagnosis is often delayed or missed. Earlier detection and intervention would improve the patients’ outcome, which currently is poor.


Author(s):  
Brendan Lanpher

The urea cycle is a series of steps required to generate urea from nitrogen produced by protein catabolism. The cycle was first described in 1932 by Krebs and Henseleit (Krebs and Henseleit 1932). Six enzymes and two transporters are necessary for urea cycle activity. Specific deficiencies have been described with each of these. The process converts nitrogen from ammonia and aspartate into urea, which is freely excreted by the kidney (Brusilow 1995). Embedded within the urea cycle is the nitric oxide cycle. Nitric oxide is generated from arginine by nitric oxide synthase (NOS), producing citrulline (Scaglia et al. 2004). The entire urea cycle is present only in the liver. The proximal cycle (N-acetylglutamate synthase [NAGS], carbamyl phosphate synthetase [CPS], ornithine transcarbamylase [OTC]) is also present in the intestinal tract, whereas the distal cycle (argininosuccinic acid synthase [ASS], argininosuccinic acid lyase [ASL], arginase [ARG]) is active in the kidney. The most common of the urea cycle disorders (UCDs) is ornithine transcarbamylase deficiency, which is inherited in an X-linked manner. All of the others are autosomal recessive. The overall incidence of all urea cycle disorders is estimated at between 1/10,000 to 1/25,000, although patients with incomplete deficiency are likely significantly more common (Nagata, Matsuda et al. 1991). When the urea cycle function is absent or diminished, either by direct enzymatic deficiency or by secondary inhibition of the proximal four steps, nitrogen accumulates in the form of toxic ammonium. In null activity patients, this typically presents in the first days of life with hyperammonemia, resulting in central nervous system (CNS) dysfunction with overwhelming encephalopathy and coma, brain edema, seizures, and potentially death, with severe long-term neurodevelopmental sequelae if not rapidly reversed. The differential diagnosis of severe hyperammonemia includes organic acidemias, herpes-related hepatitis, and other disorders of liver function. Respiratory alkalosis and hyperventilation is classically seen in UCDs, although if encephalopathy progresses, apneas and acidosis may be seen (Burton 1998). If not recognized and reversed immediately, this may progress to fatal cerebral edema and herniation. There are multiple postulated mechanisms for ammonia-related neurotoxicity.


2021 ◽  
Vol 12 ◽  
Author(s):  
Kuntal Sen ◽  
Afrouz A. Anderson ◽  
Matthew T. Whitehead ◽  
Andrea L. Gropman

The urea cycle disorders (UCD) are rare genetic disorder due to a deficiency of one of six enzymes or two transport proteins that act to remove waste nitrogen in form of ammonia from the body. In this review, we focus on neuroimaging studies in OTCD and Arginase deficiency, two of the UCD we have extensively studied. Ornithine transcarbamylase deficiency (OTCD) is the most common of these, and X-linked. Hyperammonemia (HA) in OTCD is due to deficient protein handling. Cognitive impairments and neurobehavioral disorders have emerged as the major sequelae in Arginase deficiency and OTCD, especially in relation to executive function and working memory, impacting pre-frontal cortex (PFC). Clinical management focuses on neuroprotection from HA, as well as neurotoxicity from other known and yet unclassified metabolites. Prevention and mitigation of neurological injury is a major challenge and research focus. Given the impact of HA on neurocognitive function of UCD, neuroimaging modalities, especially multi-modality imaging platforms, can bring a wealth of information to understand the neurocognitive function and biomarkers. Such information can further improve clinical decision making, and result in better therapeutic interventions. In vivo investigations of the affected brain using multimodal neuroimaging combined with clinical and behavioral phenotyping hold promise. MR Spectroscopy has already proven as a tool to study biochemical aberrations such as elevated glutamine surrounding HA as well as to diagnose partial UCD. Functional Near Infrared Spectroscopy (fNIRS), which assesses local changes in cerebral hemodynamic levels of cortical regions, is emerging as a non-invasive technique and will serve as a surrogate to fMRI with better portability. Here we review two decades of our research using non-invasive imaging and how it has contributed to an understanding of the cognitive effects of this group of genetic conditions.


2016 ◽  
Vol 04 (01) ◽  
pp. 033-043
Author(s):  
Johannes Häberle ◽  
Véronique Rüfenacht

2020 ◽  
Vol 33 (6) ◽  
pp. 721-728
Author(s):  
Özlem Saritaş Nakip ◽  
Yılmaz Yıldız ◽  
Ayşegül Tokatlı

AbstractObjectivesUrea cycle disorders (UCDs) are rare hereditary diseases. This study was conducted to help identify the characteristics of UCDs in Turkey.MethodsThe primary outcome was to determine patient characteristics. Investigating the relationships between the patient outcomes and ammonia levels were the secondary outcomes. Eighty five patients from 79 families, diagnosed with UCD at a single metabolic referral center between 1979 and 2017, were included. Clinical and laboratory data were retrieved retrospectively from hospital records.ResultsClassical citrullinemia was the most common type of UCD; citrin deficiency and carbamoyl phosphate synthase 1 deficiency (CPS1D) were the rarest. One thirty one hyperammonemic episodes were recorded. The peak ammonia levels were found to be significantly associated with polycythemia and hypocalcemia at presentation. The median peak ammonia values of the patients who died were higher than those of the survivors. The highest mortality rate was in the classical citrullinemia group. The mortality rate of the first hyperammonemic crisis was 28.6%, while it was 6.7% in subsequent episodes with an odds ratio of 4.28 (95% CI: 1.67–11.0) (p=0.001). Forty-four patients underwent genetic analysis and genetic variants were detected in 42 patients (95%). Three of the detected variants have not been previously reported.ConclusionsThis is the largest UCD series in Turkey and may serve as a guide to clinical, biochemical and genetic features of UCDs in our country. Prevention of hyperammonemia may be the most influential measure to improve long term survival.


Author(s):  
Sandesh C.S. Nagamani ◽  
Saima Ali ◽  
Rima Izem ◽  
Deborah Schady ◽  
Prakash Masand ◽  
...  

2019 ◽  
Vol 42 (6) ◽  
pp. 1176-1191 ◽  
Author(s):  
Susan E. Waisbren ◽  
Arianna K. Stefanatos ◽  
Teresa M. Y. Kok ◽  
Burcu Ozturk‐Hismi

2005 ◽  
Vol 21 (4) ◽  
pp. S9-S17 ◽  
Author(s):  
Wendy Smith ◽  
Priya S. Kishnani ◽  
Brendan Lee ◽  
Rani H. Singh ◽  
William J. Rhead ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document